Send me a link:

*Text messaging rates may apply.

 Dow Up 0.01% Nasdaq Up 0.48%

Gilead Sciences Inc. (GILD)

-NasdaqGS
93.90 Up 0.91(0.98%) 10:01AM EDT - Nasdaq Real Time Price
Prev Close:92.99
Open:94.00
Bid:94.24 x 200
Ask:94.28 x 200
1y Target Est:109.86
Beta:1.01
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:93.62 - 94.34
52wk Range:55.96 - 94.34
Volume:2,059,751
Avg Vol (3m):11,676,200
Market Cap:143.30B
P/E (ttm):34.78
EPS (ttm):2.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDUp 0.98%143.30B
GSKUp 0.64%116.10B
PFEDown 1.36%185.43B
RHHBYUp 0.96%250.73B

Key Statistics

Forward P/E (1 yr):10.39
P/S (ttm):8.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :7.67
Quarterly EPS Est (Sep-14) :1.82
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.44

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback